A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy.
Clinical trial NCT06649448 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06649448
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2025-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.